Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (148 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 May 2014 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | HSBC Multi Asset Active FOF |
|---|---|
| 05 May 2014 | ₹100.00 |
| 14 May 2015 | ₹121.96 |
| 22 May 2016 | ₹126.44 |
| 01 Jun 2017 | ₹154.27 |
| 10 Jun 2018 | ₹166.70 |
| 19 Jun 2019 | ₹169.15 |
| 27 Jun 2020 | ₹161.83 |
| 06 Jul 2021 | ₹228.10 |
| 15 Jul 2022 | ₹228.09 |
| 25 Jul 2023 | ₹269.81 |
| 02 Aug 2024 | ₹341.53 |
| 11 Aug 2025 | ₹356.56 |
| 20 Aug 2026 | ₹423.61 |
| Metric | HSBC · Regular NAV ₹42.47 Very High risk ★★★☆☆ | Category median FoF Domestic · 148 funds |
|---|---|---|
| +17.12% | +7.03% | |
| +16.16% | +13.88% | |
| +12.70% | +11.19% | |
| +11.83% | +11.61% | |
| +12.46% | +10.54% | |
| +14.70% | — | |
| +11.58% | +12.35% | |
| +11.13% | +10.37% | |
| +11.61% | +8.94% | |
| Risk | ||
| 11.21% | 15.84% | |
| 0.86 | 0.70 | |
| 1.18 | 0.97 | |
| -25.45% | -19.67% | |
| Nifty 500 | — | |
| +5.03% | +1.35% | |
| 0.66 | 0.94 | |
| 79.0% | 97.2% | |
| 39.6% | 93.6% | |
| 1.40% | 0.58% | |
| ₹106.68Cr | ₹226.32Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 10% | 10% | |
| Gautam Bhupal · 10.8y | — | |
| 05 May 2014 | — | |
| — | — | |
| — | — | |
| 4.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.